Loading...
OTC Markets
Totals
Securities
12,348
Dollar Vol
$2.6B
Share Vol
3.5B
Trades
328,121

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

EAPH
Easton Pharmaceuticals, Inc.

Common Stock
Filings and Disclosure
OTC Disclosure & News Service
Active
Inactive
All
Publish Date
Publish Date
Title
Title
Period End Date
Period End Date
Status
Status
10/04/2019Quarterly Report06/30/2019A
10/04/2019Quarterly Report03/31/2019A
05/29/2019Supplemental Information - Supplemental Report03/31/2019A
03/18/2019Annual Report12/31/2018A
01/29/2019Quarterly Report09/30/2018A
08/13/2018Quarterly Report06/30/2018A
07/31/2018Attorney Letter with Respect to Current Information03/31/2018A
07/30/2018Quarterly Report03/31/2018A
07/10/2018Attorney Letter with Respect to Current Information12/31/2017A
06/03/2018Annual Report12/31/2017A
More
Displaying 10 of 83 Disclosure & News
SEC Filings
Form Type
Form Type
Received
Received
Period End Date
Period End Date
Report
Report
10-Q/A12/30/202109/30/2021PDFRTFHTMLXLS
10-Q/A12/30/202106/30/2021PDFRTFHTMLXLS
10-Q/A12/30/202103/31/2021PDFRTFHTMLXLS
10-Q/A12/29/202103/31/2021PDFRTFHTMLXLS
10-K/A12/29/202112/31/2020PDFRTFHTMLXLS
10-K/A12/29/202112/31/2019PDFRTFHTMLXLS
10-Q12/22/202109/30/2021PDFRTFHTMLXLS
10-Q12/22/202106/30/2021PDFRTFHTMLXLS
10-Q12/22/202103/31/2021PDFRTFHTMLXLS
10-K12/22/202112/31/2020PDFRTFHTMLXLS
More
Displaying 10 of 115 Filings
Insider Disclosure
OTC Disclosure & News

No insider disclosure available for EAPH.

SEC Transactions Last 6 Months
Buy / Sell
Buys
0
Sells
0
Total
0
Shares
Bought
0
Sold
0
Gross
0
Net
0
SEC Transactions Last 2 Years

No SEC transactions available for EAPH.

Caveat Emptor Icon
This market serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing.
Expert Market
OTC Markets Group is unable to confirm this company is providing public disclosure to a regulator, an exchange, or OTC Markets Group.
Buyer Beware: OTC Markets Group has determined that there is a public interest concern associated with the company.
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.